Mitochondrial DNA mutations in cardiomyopathy: combination of replacements yielding cysteine residues and tRNA mutations

Muscle Nerve Suppl. 1995:3:S165-9. doi: 10.1002/mus.880181432.

Abstract

Mutations occur in mitochondrial DNA (mtDNA) in a strand-asymmetric manner. The suppressed usage of cysteine residues in the H-strand-encoded subunits can be ascribed to the mutational instability of the codon for cysteine. The usage of cysteine was suppressed even in the L-strand-encoded ND6 subunit in which the codon for cysteine was stable. Survey of the entire sequences of mtDNA from 43 individuals revealed three amino acid replacements creating cysteine residues. A patient with fatal infantile cardiomyopathy carried a mutation causing a Tyr-->Cys replacement along with three tRNA mutations. A patient with hypertrophic cardiomyopathy carried two mutations causing a Ser-->Cys replacement and a Tyr-->Cys replacement besides two tRNA mutations. The gain of cysteine residues might accelerate the inactivation of the subunits either by reactive oxygen species or by lipid-peroxidation products, and this gain, possibly in association with tRNA mutations, can be a genetic risk factor for degenerative diseases.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Cardiomyopathies / genetics*
  • Cardiomyopathy, Hypertrophic / genetics
  • Codon
  • Cysteine / genetics*
  • Cysteine / metabolism
  • DNA, Mitochondrial / genetics*
  • Humans
  • Infant
  • Male
  • Molecular Sequence Data
  • Mutation*
  • RNA, Transfer / genetics*

Substances

  • Codon
  • DNA, Mitochondrial
  • RNA, Transfer
  • Cysteine